Crossmark

An <scp>FGFR</scp> 3/ <scp>MYC</scp> positive feedback loop provides new opportunities for targeted therapies in bladder cancers

Crossref DOI link: https://doi.org/10.15252/emmm.201708163

Published Online: 2018-02-20

Published Print: 2018-04

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Mahe, Mélanie

Dufour, Florent

Neyret‐Kahn, Hélène

Moreno‐Vega, Aura

Beraud, Claire

Shi, Mingjun

Hamaidi, Imene

Sanchez‐Quiles, Virginia

Krucker, Clementine

Dorland‐Galliot, Marion

Chapeaublanc, Elodie

Nicolle, Remy

Lang, Hervé

Pouponnot, Celio

Massfelder, Thierry

Radvanyi, François

Bernard‐Pierrot, Isabelle https://orcid.org/0000-0002-8967-5092
Funding

Funding for this research was provided by:

Ligue Contre le Cancer

Institut National Du Cancer
License Information

Version of Record valid from 2018-02-20
More Information

Publication History

Received: 2017-06-15

Accepted: 2018-01-23

Published: 2018-02-20